Last update:
Weight management news
Experimental obesity drug targets appetite through amylin, offering potential alternative to GLP-1 therapies
New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2), and published in The Lancet Diabetes & Endocrinology shows that weekly injections ...
15 minutes ago
0
0
Focusing on the 'obesity paradox' to improve cancer treatment success
In research published in the journal Nature, McGill University researchers looked at the relationship between diet, the gut microbiome and patient response to immune checkpoint blockade. To their surprise, certain diets often ...
3 hours ago
0
0
GLP-1s appear safe for treating diabetes in pregnancy, but evidence gaps remain
New research to be presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2), and published in The Lancet Obstetrics, Gynaecology & Women's Health shows ...
3 hours ago
0
0
Major trial examines sugar-free sweetened soft drinks
Researchers at the University of Liverpool have conducted the longest and most comprehensive randomized controlled trial of non-nutritive sweetened (NNS) soft drinks.
Sep 29, 2026
0
498
Cutting calories sheds weight initially, but body changes can drive regain
In the last few years, there's been a lot of interest in calorie-restricted diets for weight loss.
Sep 29, 2026
0
6
Q&A: What are ultra-processed foods?
Nearly every day, there's a headline about ultra-processed foods, which have been linked to harmful health effects despite lacking a universally accepted definition. These foods are the subject of numerous proposed regulations, ...
Sep 29, 2026
0
4
EU launches first Screening Week to help detect heart and diabetes risks earlier
At a press conference at the EASD Annual Meeting in Milan, organized by the European Diabetes Forum (EUDF), three leading European cardiometabolic scientific associations—the European Society of Cardiology (ESC), the European ...
Sep 29, 2026
0
3
How much do Americans spend on GLP-1 medications? Medical students measure drug affordability
The number of people using GLP-1 treatments like Ozempic and Wegovy for weight loss or chronic conditions has increased rapidly, with more than 1 in 10 U.S. adults currently taking such medications. A new study led by medical ...
Sep 28, 2026
0
10
Regulator-mandated study finds no link between semaglutide use and pancreatic cancer
New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, found no link between semaglutide use and pancreatic cancer in nationwide registry ...
Sep 28, 2026
0
16
Millions more people with overweight could benefit from GLP-1 drugs to protect heart health, study suggests
New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, makes a case for extending the indication for GLP-1 receptor agonists (GLP1-RAs) ...
Sep 27, 2026
0
21
Daily oral GLP-1 medication linked to similar weight loss across three menopausal stages
New analyses to be presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, show that orforglipron, a daily oral medication for weight loss and type 2 ...
Sep 26, 2026
0
173
The higher your body fat percentage, the less accurate your smartwatch is at measuring calories burned
Smartwatches have become an increasingly popular way for people to monitor their health and fitness. About 100 million—nearly 4 in 10—U.S. adults own a smartwatch. Worldwide, market research estimates approximately 560 million ...
Sep 26, 2026
0
27
Newfound brain circuit coordinates eating and energy burning when temperatures drop
When the body's temperature falls, it adapts by burning more energy to generate heat and triggering appetite to replace the fuel used to stay warm. While scientists have known about those responses for decades, precisely ...
Sep 25, 2026
0
61
Underweight patients face 92% higher odds of death after emergency general surgery
Underweight patients are more likely to die after emergency general surgery than patients who are normal weight or overweight, and patients who are both frail and underweight face an even higher risk of death and other adverse ...
Sep 25, 2026
0
7
Cholesterol control gets personalized—how new guidelines tailor treatment to your unique risk profile
At least a quarter of Americans have high levels of cholesterol or fatty acids in their blood, a condition called dyslipidemia. Uncontrolled cholesterol levels increase the risk of atherosclerotic cardiovascular disease, ...
Sep 24, 2026
0
14
Study links weight stigma and cultural attitudes to well-being
A person's body size or type, and how well it conforms with society's expectations, can be a source of stress in many cultures. University of Mississippi psychologists examined how people's experiences and perceptions of ...
Sep 24, 2026
0
6
Health communication expert finds GLP-1 users face stigma within their social circles
People taking popular GLP-1 medications such as Ozempic, Wegovy and Zepbound may face stigma from those closest to them, according to a new study by a Florida State University professor.
Sep 24, 2026
0
6
High-fat diets suppress enzyme in immune cells, promoting fat tissue inflammation in mice
A group of innate immune cells, known as group 2 lymphoid cells (ILC2), are essential for maintaining a stable metabolism in adipose tissue. Obesity significantly impairs the number and function of ILC2 cells, leading to ...
Sep 23, 2026
0
100
Study finds brain differences linked to obesity risk in preschoolers
Children as young as 4 with a higher body mass index (BMI) show differences in several brain regions involved in reward, taste and hunger, according to a new study from Florida International University. The findings suggest ...
Sep 23, 2026
0
10
Weight loss alone does not explain lower heart disease risk for those on semaglutide
Semaglutide is known to reduce the risk of serious heart disease. However, a new study published in the European Heart Journal suggests that this effect cannot be entirely explained by patients losing weight on the drug.
Sep 23, 2026
0
21
Strength training causes fat cells to shrink even before weight loss, study suggests
Just seven days of strength training increased visceral fat burning in obese mice, even before any weight loss could be seen on a scale. In an experiment conducted at the State University of Campinas (UNICAMP), researchers ...
Sep 22, 2026
0
774
Mothers' poor sleep quality in late pregnancy linked to higher obesity risk in their children
New research has found that mothers with poor sleep quality in late pregnancy had babies with lower weight in the first six months of life but higher weight at ages 1–2 years. This effect was strongest in male infants and ...
Sep 22, 2026
0
46
RNA therapy may help preserve muscle during GLP-1 weight loss
GLP-1 drugs have revolutionized obesity treatment, but they can lead people to lose muscle mass along with fat. And when patients stop treatment, they often regain their weight—primarily as fat.
Sep 21, 2026
0
133
Experimental drug raises energy expenditure but fails to activate brown fat in human study
Brown fat burns energy to generate heat and is therefore considered a promising target for new obesity treatments. Researchers at the University of Basel and University Hospital Basel have tested whether a drug can activate ...
Sep 21, 2026
0
127
